Technology | April 29, 2015

Varian Unveils VitalBeam for Affordable Advanced Radiotherapy

Configurable radiotherapy platform offers IMRT, low-dose megavoltage and respiratory gating

Varian, VitalBeam, IMRT, ESTRO, radiotherapy

April 29, 2015 — Varian Medical Systems last week unveiled a radiotherapy platform designed to offer clinics an affordable option for implementing advanced image-guided radiotherapy. Varian's VitalBeam system is a cost-effective technology package for offering high-quality, high-throughput radiation therapy, and for expanding clinical capabilities over time.

VitalBeam will be available in a basic package with an 80-leaf collimator for intensity-modulated radiation therapy (IMRT), low-dose megavoltage (MV) imaging using the accelerator beam for image guidance and respiratory gating for motion management. Clinics can add RapidArc radiotherapy for faster IMRT, higher dose delivery rates, an onboard kV X-ray system capable of cone-beam computed tomography (CBCT) imaging and a higher-resolution 120-leaf collimator. All VitalBeam configurations offer up to three photon and six electron energy levels for flexibility in treatment.

VitalBeam incorporates Varian's next-generation system architecture, originally developed for the TrueBeam platform, which dynamically synchronizes imaging, patient positioning, motion management, beam shaping and dose delivery, performing accuracy checks every ten milliseconds.

Other VitalBeam features include:

  • A streamlined treatment console with a modern, easy-to-use, graphical interface that consolidates controls for imaging, treatment and motion management in one place.
  • A "follow the light" guidance system, with prompts and messages that enhances safety by guiding therapists through the steps of even the most complex treatments.
  • "Intelligent" automation that saves time by reducing the number of steps needed for imaging, positioning and treating patients.

 

Varian introduced the VitalBeam platform at the 2015 European Society for Radiotherapy and Oncology (ESTRO) annual meeting.

For more information: www.varian.com

Related Content

Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Radiation Therapy | May 10, 2019
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
The novel nanoparticle is designed to enhance radiation killing of cancer cells in the radiation resistant low-oxygen tumor core

The novel nanoparticle is designed to enhance radiation killing of cancer cells in the radiation resistant low-oxygen tumor core. Credit: Wenpei Fan, LOMIN Laboratory, NIBIB.

News | Radiation Therapy | May 08, 2019
Radiation kills tumors by creating oxygen free radicals that damage the tumor DNA. However, the lack of oxygen in the...